Mckesson Medical-Surgical Inc. Corporate Office recalls Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Free
Recalled August 17, 2022 · FDA recall D-1325-2022 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
CGMP Deviations: products were stored outside the drug label specifications. · FDA Class II
Units
23 cartons
Sold at
Nationwide in the USA.
Description
CGMP Deviations: products were stored outside the drug label specifications.
Product
Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Free, 30 x 0.5 mL Sterile Unit-of-Use Vials, each in a foil pouch, per carton, Nephron Pharmaceuticals Corporation, NDC 0487-5901-99.
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →